Katherine L. Horton

Katherine L. Horton

Auto-generated profile, based on publicly available information

Katherine L. Horton

School of Clinical and Experimental Sciences, University of Southampton Faculty of Medicine, Southampton, UK

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2022 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Closed access
PDF file
NMNaseeb Malhi
Naseeb Malhi
CAClaire L. Allen
Claire L. Allen
ESElizabeth Stewart
Elizabeth Stewart
KHKatherine L. Horton
Katherine L. Horton
FRFederica Riu
Federica Riu
DBDave Bates
Dave Bates
Angiogenic VEGF isoforms are upregulated in diabetic retinopathy (DR), driving pathological growth and fluid leakage. Serine-arginine-rich protein kinase-1 (SRPK1) regulates VEGF splicing, and its inhibition blocks angiogenesis. We tested the hypothesis that SRPK1 is activated in diabetes, and an SRPK1 inhibitor (SPHINX31) switches VEGF splicing in DR and prevents increased vascular permeability into the retina. SRPK1 was activated by high glucose (HG), in a PKC-dependent manner, and was blocked by SPHINX31. HG induced release of SRSF1 from the nuclear speckles, which was also SRPK1 dependent, and increased retinal pigment epithelial (RPE) monolayer admittance, which was reversed by SRPK1 inhibition (P < 0.05). Diabetes increased retinal permeability and thickness after 14 days which was blocked by treatment with SPHINX31 eye drops (P < 0.0001). These results show that SRPK1 inhibition, administered as an eye drop, protected the retinal barrier from hyperglycemia-associated loss of integrity in RPE cells in vitro and in diabetic rats in vivo. A clinical trial of another SRPK1 inhibitor has now been initiated in patients with diabetic macular edema. NEW & NOTEWORTHY VEGF-A165b splicing is induced by hyperglycemia through PKC-mediated activation of SRPK1 in RPE cells, increasing their permeability and angiogenic capability. SRPK1 inhibitors can be given as eye drops to reduce retinal permeability and edema in diabetic retinopathy. Listen to this article’s corresponding podcast at https://ajpheart.podbean.com/e/srpk1-eye-drops-as-a-treatment-for-diabetic-retinopathy/.

1 January 2025 in European Respiratory Review
Verified
Journal Article
Open access
PDF file
KHKatie Horton
Katie Horton
PWPeter A.C. Wing
Peter A.C. Wing
CJClaire L. Jackson
Claire L. Jackson
CMChristopher J. McCormick
Christopher J. McCormick
MCMary P. Carroll
Mary P. Carroll
JLJane S Lucas
Jane S Lucas
The airway epithelium is the first point of contact for inhaled pathogens. The role of epithelial cells in clearance, infection and colonisation of bacteria is established. The interactions of respiratory viruses and cilia is less understood, but viruses are known to target ciliated epithelial cells for entry, replication and dissemination. Furthermore, some respiratory viruses impair and/or enhance ciliary activity. This review examines what is known about the interactions between cilia and viral infection and how respiratory viruses effect cilia function with subsequent consequences for human health. We discuss the models which can be used to investigate the relationship between respiratory viruses and the host airway.

26 January 2023 in ERJ Open Research
Verified
Journal Article
Open access
PDF file
RBRadhika Banka
Radhika Banka
KCKiarina Chichirelo-Konstantynovych
Kiarina Chichirelo-Konstantynovych
KHKatie L. Horton
Katie L. Horton
TKTetyana Konstantynovych
Tetyana Konstantynovych
MLMerete B. Long
Merete B. Long
HKHolly Keir
Holly Keir
The European Respiratory Society International Congress took place both in person, in Barcelona, Spain, and online in 2022. The congress welcomed over 19 000 attendees on this hybrid platform, bringing together exciting updates in respiratory science and medicine from around the world. In this article, Early Career Members of the Respiratory Infections Assembly (Assembly 10) summarise a selection of sessions across a broad range of topics, including presentations on bronchiectasis, nontuberculous mycobacteria, tuberculosis, cystic fibrosis and coronavirus disease 2019.